Six months ago, the federal government loudly proclaimed the likely benefits of an existing drug called leucovorin for ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

By Dennis Thompson HealthDay ReporterTHURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbound and vice versa within the ...

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics ...

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Center for Weight Loss Surgery explains the differences between duodenal switch and gastric sleeve surgeries for weight loss.

Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...

Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to ...

GLP-1 cost pressure is now a talent retention issue. A new study found that 29% of employees would switch jobs for coverage.